{"schema_version":"1","generated_at":"2026-11-01T04:28:27.685Z","data_as_of":"2026-10-28","url":"https://www.findmykol.com/kol/holly-meany","json_url":"https://www.findmykol.com/kol/holly-meany/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"holly-meany","name":"Holly Meany","credential":"MD","title":"Director, Solid Tumor Program","specialty":"Hematology / Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Pediatric","therapeutic_areas":["Pediatric","Neuro-Oncology","Sarcoma"],"institution":"Children's National Hospital","institution_url":"https://www.findmykol.com/institution/children-s-national-hospital","city":"Washington","state":"DC","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1194810325","orcid":"0000-0002-2230-8351","openalex":"A5020298914"},"summary":"Holly Meany is Director, Solid Tumor Program at Children's National Hospital. OpenAlex indexes 42 publications with 668 citations (h-index 17); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Holly Meany, MD, is Director, Solid Tumor Program at Children's National Hospital. The public record shows 42 publications with 668 citations (h-index 17), centered on Neuroblastoma Research and Treatments, Glioma Diagnosis and Treatment, Neurofibromatosis and Schwannoma Cases. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 5 companies.","bullets":["Most recent indexed publication: 2026 · Nature medicine","Top research focus: Neuroblastoma Research and Treatments","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 5 companies"],"generated_at":"2026-10-31"},"focus":{"indications":[{"label":"Neuroblastoma","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":3,"topics":1,"strength":10},{"label":"Coma","therapeutic_area":"Neurology","trials":3,"topics":0,"strength":9},{"label":"Sarcoma, Ewing","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Rhabdomyosarcoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Myosarcoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"Ganglioneuroblastoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Liver Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Kidney Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Central Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Nervous System Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neoplasms, Germ Cell and Embryonal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurofibromatosis 1","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurofibromatoses","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Neurofibroma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Fibroma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Wilms Tumor","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Neuroblastoma Research and Treatments","Glioma Diagnosis and Treatment","Neurofibromatosis and Schwannoma Cases","Sarcoma Diagnosis and Treatment","CAR-T cell therapy research"],"drugs_studied":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"DANYELZA","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"IWILFIN","trials":0,"payments":1,"publications":0,"mentions":1},{"name":"Pedmark","generic":"Thiosulfate","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":10,"shown":3,"withheld":7,"rows":[{"name":"Uswm, LLC","trials":0,"payments":3,"mentions":3},{"name":"Y-mAbs Therapeutics, Inc.","trials":0,"payments":3,"mentions":3},{"name":"Bayer Healthcare Pharmaceuticals Inc.","trials":0,"payments":1,"mentions":1}]}},"scholarship":{"works_count":42,"cited_by_count":668,"h_index":17,"i10_index":19,"pubmed_count":3,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07172958","title":"Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"Children's National Research Institute","source_url":"https://clinicaltrials.gov/study/NCT07172958","trial_url":"https://www.findmykol.com/trial/NCT07172958"},{"nct":"NCT06541847","title":"A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Healx Limited","source_url":"https://clinicaltrials.gov/study/NCT06541847","trial_url":"https://www.findmykol.com/trial/NCT06541847"},{"nct":"NCT02176967","title":"Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma","phase":"PHASE3","status":"ACTIVE_NOT_RECRUITING","role":"Investigator","sponsor":"Children's Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT02176967","trial_url":"https://www.findmykol.com/trial/NCT02176967"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2022,"last":2024},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Bayer Healthcare Pharmaceuticals Inc.","program_year":2024,"amount_usd":1785,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194810325"},{"payer":"USWM, LLC","program_year":2024,"amount_usd":37.31,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194810325"},{"payer":"USWM, LLC","program_year":2023,"amount_usd":14000,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194810325"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1194810325","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":6,"years":{"first":2008,"last":2024},"societies":["ASCO","ASTRO"],"shown":3,"withheld":3,"rows":[{"title":"Impact of an objective scoring system on initiation of therapy in patients with International Neuroblastoma Risk Group Staging System (INRGSS) stage MS neuroblastoma: A report from the Children’s Oncology Group.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.10003","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.10003","status":"verified"},{"title":"High Incidence of Local and Regional Failure in Pediatric Rhabdomyosarcoma of the Nasal ALA","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2019,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2019.06.235","source_url":"https://doi.org/10.1016/j.ijrobp.2019.06.235","status":"verified"},{"title":"Ex vivo expanded multi-antigen specific lymphocytes for the treatment of solid tumors.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2018,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.3042","source_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.3042","status":"verified"}],"source":"congress"},"publications":{"total":3,"shown":3,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.","year":2026,"journal":"Nature medicine","types":["Published Erratum"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42487062/","status":"verified"},{"title":"Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.","year":2026,"journal":"Nature medicine","types":["Journal Article","Clinical Trial, Phase I"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42380677/","status":"verified"},{"title":"Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.","year":2021,"journal":"Pediatric blood & cancer","types":["Clinical Trial, Phase I","Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/34383370/","status":"verified"}],"most_cited":{"total":42,"shown":5,"withheld":37,"rows":[{"title":"Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study","year":2019,"cited_by_count":78,"type":"article","source_url":"https://doi.org/10.1200/jco.19.00177"},{"title":"18‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST)","year":2012,"cited_by_count":71,"type":"article","source_url":"https://doi.org/10.1002/pbc.24212"},{"title":"Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531","year":2018,"cited_by_count":59,"type":"article","source_url":"https://doi.org/10.1200/jco.18.00419"},{"title":"Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma","year":2006,"cited_by_count":55,"type":"article","source_url":"https://doi.org/10.1002/pbc.20797"},{"title":"Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project","year":2014,"cited_by_count":42,"type":"article","source_url":"https://doi.org/10.1002/pbc.25134"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Catherine M. Bollard","coauthored_works":8},{"name":"Frank M. Balis","coauthored_works":8},{"name":"Elizabeth Fox","coauthored_works":8,"profile_url":"https://www.findmykol.com/kol/elizabeth-fox"}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"doximity","url":"https://www.doximity.com/pub/holly-meany-md","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, The Ohio State University College of Medicine, Columbus, OH (2000)","source_url":"https://research.childrensnational.org/people/meany-holly","status":"verified","collected_at":"2026-10-31"},{"value":"BS, The College of William & Mary, Williamsburg, VA (1995)","source_url":"https://research.childrensnational.org/people/meany-holly","status":"verified","collected_at":"2026-10-31"}]},"roles":{"total":6,"shown":3,"rows":[{"value":"Developmental Therapeutics Committee Member (2013-2020)","source_url":"https://cme.inova.org/node/2422/bio/3119/view","status":"verified","collected_at":"2026-10-31"},{"value":"Institutional Review Board Member (2007-present)","source_url":"https://cme.inova.org/node/2422/bio/3119/view","status":"verified","collected_at":"2026-10-31"},{"value":"Member, American Society of Clinical Oncology (2006-present)","source_url":"https://cme.inova.org/node/2422/bio/3119/view","status":"verified","collected_at":"2026-10-31"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Top Doctor, Northern Virginia Magazine (2024, 2025, 2026)","source_url":"https://appointments.childrensnational.org/provider/holly-meany/2359741","status":"provisional","collected_at":"2026-10-31"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Associate Professor of Pediatrics, George Washington University School of Medicine and Health Sciences","source_url":"https://research.childrensnational.org/people/meany-holly","status":"verified","collected_at":"2026-10-31"}]}},"similar":[{"name":"Catherine Bollard","slug":"catherine-bollard","institution":"Children's National Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/catherine-bollard","json_url":"https://www.findmykol.com/kol/catherine-bollard/profile.json"},{"name":"Brian Rood","slug":"brian-rood","institution":"Children's National Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brian-rood","json_url":"https://www.findmykol.com/kol/brian-rood/profile.json"},{"name":"Shideh Majidi","slug":"shideh-majidi","institution":"Children's National Hospital","specialty":"Pediatric Endocrinology","url":"https://www.findmykol.com/kol/shideh-majidi","json_url":"https://www.findmykol.com/kol/shideh-majidi/profile.json"},{"name":"Aerang Kim","slug":"aerang-kim","institution":"Children's National Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/aerang-kim","json_url":"https://www.findmykol.com/kol/aerang-kim/profile.json"},{"name":"Bruce Korf","slug":"bruce-korf","institution":"University of Alabama at Birmingham","specialty":"Clinical Genetics (M.D.)","url":"https://www.findmykol.com/kol/bruce-korf","json_url":"https://www.findmykol.com/kol/bruce-korf/profile.json"},{"name":"Crystal Mackall","slug":"crystal-mackall","institution":"Stanford University School of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/crystal-mackall","json_url":"https://www.findmykol.com/kol/crystal-mackall/profile.json"},{"name":"Wayne Furman","slug":"wayne-furman","institution":"St. Jude Children's Research Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/wayne-furman","json_url":"https://www.findmykol.com/kol/wayne-furman/profile.json"},{"name":"Clare Twist","slug":"clare-twist","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/clare-twist","json_url":"https://www.findmykol.com/kol/clare-twist/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":4,"congress":3,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-31"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-31"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2024","collected_at":"2026-10-31"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-31"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-31"}},"methodology_url":"https://www.findmykol.com/about#methodology"}